Literature DB >> 17258539

Effect of chronic hyperglycemia on intraocular pressure in patients with diabetes.

Toshiyuki Oshitari1, Naoya Fujimoto, Katsuhiro Hanawa, Emiko Adachi-Usami, Sayon Roy.   

Abstract

PURPOSE: To investigate the effect of chronic hyperglycemia on intraocular pressure (IOP) in patients with diabetes.
DESIGN: Cross-sectional study.
METHODS: We prospectively measured the IOP by Goldmann applanation tonometry in patients with diabetes with mild hyperglycemia (glycosylated hemoglobin A1c (HbA1c) < or = 6.5%), moderate hyperglycemia (6.5% < HbA1c < 8.0), and severe hyperglycemia (HbA1c > or = 8.0%). None of the patients with diabetes had diabetic retinopathy, secondary glaucoma, ocular or laser therapy, or history of glaucoma. The HbA1c level determined within three months of the IOP measurement was used. Statistical analysis was performed by Mann-Whitney U test. P < .05 was considered significant.
RESULTS: The mean IOP in the mild group (n = 58) was 15.5 +/- 2.5 mm Hg, which was statistically significantly lower than that of the severe group (16.6 +/- 2.4 mm Hg; P = .013; n = 60).
CONCLUSIONS: Chronic hyperglycemia is associated with increased IOP in patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17258539     DOI: 10.1016/j.ajo.2006.09.033

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  11 in total

1.  Anthropometric measures and their relation to incident primary open-angle glaucoma.

Authors:  Louis R Pasquale; Walter C Willett; Bernard A Rosner; Jae Hee Kang
Journal:  Ophthalmology       Date:  2010-04-10       Impact factor: 12.079

2.  Intraocular pressure and aqueous humor flow during a euglycemic-hyperinsulinemic clamp in patients with type 1 diabetes and microvascular complications.

Authors:  James T Lane; Luann Larson; Shan Fan; Julie A Stoner; Eyal Margalit; Carol B Toris
Journal:  BMC Ophthalmol       Date:  2010-06-23       Impact factor: 2.209

3.  Diabetes, glycemic control and risk of medical glaucoma treatment: A population-based case-control study.

Authors:  Lotte G Welinder; Anders H Riis; Lars L Knudsen; Reimar W Thomsen
Journal:  Clin Epidemiol       Date:  2009-08-09       Impact factor: 4.790

Review 4.  Myopia and diabetes mellitus as modificatory factors of glaucomatous optic neuropathy.

Authors:  Etsuo Chihara
Journal:  Jpn J Ophthalmol       Date:  2013-08-15       Impact factor: 2.447

5.  Modulation of angiogenesis by genetic manipulation of ATF4 in mouse model of oxygen-induced retinopathy [corrected].

Authors:  Xiaoqin Wang; Guibo Wang; Mansi Kunte; Vishal Shinde; Marina Gorbatyuk
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-03       Impact factor: 4.799

6.  Intraocular pressure and its determinants in subjects with type 2 diabetes mellitus in India.

Authors:  Sayantan Biswas; Rajiv Raman; Vaitheeswaran Koluthungan; Tarun Sharma
Journal:  J Prev Med Public Health       Date:  2011-07

7.  DBA/2J mice are susceptible to diabetic nephropathy and diabetic exacerbation of IOP elevation.

Authors:  Ileana Soto; Gareth R Howell; Cai W John; Joseph L Kief; Richard T Libby; Simon W M John
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

8.  Increased Intraocular Pressure and Hyperglycemic Level in Diabetic Patients.

Authors:  Maggie B Hymowitz; Donny Chang; Edward B Feinberg; Sayon Roy
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

Review 9.  Diabetes Mellitus as a Risk Factor in Glaucoma's Physiopathology and Surgical Survival Time: A Literature Review.

Authors:  Lívio Costa; João Paulo Cunha; Duarte Amado; Luís Abegão Pinto; Joana Ferreira
Journal:  J Curr Glaucoma Pract       Date:  2016-02-02

10.  The synergistic effect of inflammation and metabolic syndrome on intraocular pressure: A cross-sectional study.

Authors:  I-Te Lee; Jun-Sing Wang; Chia-Po Fu; Chia-Jen Chang; Wen-Jane Lee; Shih-Yi Lin; Wayne Huey-Herng Sheu
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.